SESSION 5

CML

P. le Coutre, A. Hochhaus

9:30 - 9:35

Introduction by the chair

9:35 - 10:00

CML update 2024

P. te Boekhorst

10:00 - 10:25

Role of IFN in CML

A. Hochhaus

10:25 - 11:20

BREAK

SESSION 6

WHAT THE FUTURE HOLDS

J. Schwarz, A. Hatálová

11:20 - 11:25

Introduction by the chair

11:25 - 11:50

Challenges in the introduction of novel treatment modalities for MPN

R. Kralovics

11:50 - 12:20

Ongoing clinical research

J.J. Kiladjian

12:20 - 12:30

Farewell on behalf of CEMPO

H. Gisslinger